Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Oct 15, 2019
Date Accepted: Apr 8, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Mobile phone technologies in the management of ischaemic heart disease, heart failure and hypertension: A systematic review and meta-analysis.
ABSTRACT
Background:
Cardiovascular disease (CVD) remains the leading cause of death in the world. Mobile phones have become ubiquitous in most developed societies. Smartphone applications, telemonitoring and clinician-driven short message service (SMS) allow for novel opportunities and methods in managing chronic cardiovascular conditions such as ischaemic heart disease, heart failure and hypertension. A systematic review was conducted using seven electronic databases, identifying all relevant randomised control trials (RCTs) featuring a mobile phone-based intervention (MPI) used in the management of these conditions. Outcomes assessed included mortality, hospitalisations, blood pressure and body mass index.
Conclusions:
T
Objective:
The aim of this paper is to systematically review and meta-analyse the evidence for mobile phone technology in the management of cardiac conditions according to the following questions: (i) What are the specific interventions available and do they involve an interface whereby the clinician can use the data to intervene (henceforth referred to as a “back-end”) ii) Can mobile phone technologies improve patient outcomes with respect to mortality and hospitalisations, and (iii) Can mobile phone technologies reduce risk factors for cardiac events, specifically medication compliance and hypertension?
Methods:
Methods and
Results:
Twenty-six RCTs including 6,713 patients were identified and are described within the present review, and twelve were included for meta-analysis.
Results:
In patients with heart failure, MPIs were associated with a significantly lower rate of hospitalisations. In patients with hypertension, patients exposed to MPIs had a significantly lower systolic blood pressure.
Conclusions:
The available data suggests MPIs may have a role as valuable adjuncts in the management of chronic CVD.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.